O. Valverde et al., ANTINOCICEPTION INDUCED BY EXOGENOUS AND ENDOGENOUS OPIOIDS - ROLE OFDIFFERENT BRAIN STRUCTURES, Regulatory peptides, 54(1), 1994, pp. 309-310
RB 101, the mixed inhibitor of the enkephalin degrading enzymes able t
o cross the blood brain barrier induced similar antinociceptive effect
s to exogenous opiates, but produced less tolerance and dependence aft
er chronic treatment (1). In this study we have investigated the parti
cipation of several brain structures in antinociception induced after
exogenous opioid injection or activation of the endogenous opioid syst
em with RB 101. Rats were implanted with cannulae into thalamus ventro
-basal (THB), central amygdala (AMG), periaqueductal gray matter (FAG)
and raphe magnus nucleus (NRM). The antinociceptive responses induced
by systemic injection of morphine or RB 101 were evaluated in the tai
l electrical-stimulation test after local administration of the opioid
antagonist methylnaloxonium (MN) into the implanted structures. The b
lockade of morphine and RB 101 antinociception was similar after MN ad
ministration in the THB, FAG and NRM. However, morphine responses were
more efficiently blocked than the responses induced by RB101 when MN
was injected into the AMG. This result suggests a different implicatio
n of AMG in endogenous and exogenous opioids induced antinociception.